Disseminated tuberculosis after anti-TNFα treatment

Lancet

Volumn 370, Issue 9587, 2007, Pages 564-

  Iizuka, Masahiro ^a   Watanabe, Sumio ^b  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ADALIMUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

HUMAN; LETTER; MILIARY TUBERCULOSIS; MYCOBACTERIOSIS; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; TUBERCULIN TEST; CHEMICALLY INDUCED DISORDER; NOTE; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SKIN TEST;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; SKIN TESTS; TUBERCULOSIS, MILIARY;

EID: 34547837409     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61289-6     Document Type: Letter

References (4)

1. Malipeddi A., Rajendran R., and Kallarackal G. Disseminated tuberculosis after anti-TNFα treatment. Lancet 369 (2007) 162
2. Fonseca J., Canhao H., Silva C., et al. Tuberculosis in rheumatic patients treated with tumor necrosis factor alpha antagonists: the Portuguese experience. Acta Reumatol Port 31 (2006) 247-253
3. Stas P., D'Hoore A., Van Assche G., Geboes K., et al. Miliary tuberculosis following infliximab therapy for Crohn disease: a case report and review of the literature. Acta Gastroenterol Belg 69 (2006) 217-220
4. Okubo H., Iwamoto M., Yoshio T., et al. Rapidly aggravated Mycobacterium avium infection in a patient with rheumatoid arthritis treated with infliximab. Mod Rheumatol 15 (2005) 62-64